Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1CNS 1

Conditions

Leukemia, Myeloid, Acute 229Leukemia, Lymphocytic, Chronic, B-Cell 213Leukemia 203Myelodysplastic Syndromes 182Precursor Cell Lymphoblastic Leukemia-Lymphoma 174Lymphoma, Non-Hodgkin 121Lymphoma 120Hodgkin Disease 108Multiple Myeloma 107Lymphoma, Follicular 100Lymphoma, Mantle-Cell 99Lymphoma, Large B-Cell, Diffuse 86Lymphoma, B-Cell, Marginal Zone 85Congenital Abnormalities 85Myeloproliferative Disorders 84Burkitt Lymphoma 81Leukemia, Myelomonocytic, Chronic 77Leukemia, Myelogenous, Chronic, BCR-ABL Positive 75Leukemia, Myeloid, Chronic-Phase 74Leukemia, Myeloid, Accelerated Phase 73Lymphoma, Large-Cell, Immunoblastic 61Anemia, Refractory, with Excess of Blasts 60Blast Crisis 55Primary Myelofibrosis 53Waldenstrom Macroglobulinemia 52Neoplasms, Plasma Cell 52Recurrence 48Hematologic Neoplasms 45Dendritic Cell Sarcoma, Interdigitating 42Leukemia, Prolymphocytic 41

Interventions

trametinib 2fludarabine 2thymoglobulin 1omipalisib 1fludarabine phosphate 1Rituximab 1Melphalan 1Levetiracetam 1Injections 1Cytarabine 1Cyclophosphamide 1Busulfan 1Biopsy 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibromatosis 1 × fludarabine phosphate × Other hematologic neoplasm × Clear all
NCT05849662 2026-04-15

A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia

Therapeutic Advances in Childhood Leukemia Consortium

Phase 1/2 Recruiting
58 enrolled
CNSOther hematologic neoplasm

Neurofibromatosis 1, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡